BPTH Total Utang marang Modal Bio-Path

BPTH (Bio-Path Holdings, Inc.) - tandha merek perusahaan

Bio-Path Holdings (BPTH) focuses on implementing antisense molecules for leukemia therapy, seeking to attract investment through clinical reports. Processes rely on bioethics and eco-friendly waste disposal. This chart of the total debt-to-equity ratio is fixed at 0.00. The business operates under intense competition with biotech leaders, where success is determined solely by high drug efficacy.

Rasio Utang marang Ekuitas: biopathholdings.com (BPTH) kanggo 04.07.2022 - 01.03.2025

Rincian metrik komprehensif lan analitis Bio-Path Holdings, Inc (BPTH)

- rega lan prakiraan konsensus rega:
Rega saham Bio-Path Holdings, Inc.|BPTH - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Bio-Path Holdings|BPTH - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Bio-Path Holdings|BPTH - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku biopathholdings.com|BPTH - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Bio-Path Holdings|BPTH - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Bio-Path Holdings|BPTH - Kewajiban utang agregat|Utang marang nilai buku Bio-Path Holdings
Analisis komprehensif perusahaan:BPTH - Bio-Path Holdings, Inc.
Sampel barang Bio-Path Holdings

The total debt-to-equity ratio measures the proportion of borrowed funds within the financing structure, determining the business's level of dependence on creditors and the associated default risks. By analyzing the current total liabilities-to-equity level, an investor assesses the financial stability of Bio-Path Holdings (BPTH), whose investments in the DNAbilize platform for targeted cancer therapy require strict control over the debt load.

Pesaing utama

Total Utang marang Modal TGTX|Rasio Total Utang marang Ekuitas Arcellx Inc|Total Utang marang Modal IRON|Total Utang marang Modal SNDX (Syndax Corp)|KURA - Utang marang Ekuitas|Rasio Utang marang Ekuitas adctherapeutics.com ADCT|FHTX: Total Utang marang Modal|VOR - Rasio Total Utang marang Ekuitas|Total Utang marang Modal NKTX|COEP (Coeptis Therapeutics, Inc.) - Utang marang Modal|ATNM - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi estrellabio.com (ESLA)|CASI Pharmaceuticals (CASI) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi markertherapeutics.com (MRKR)|Total Utang marang Modal IN8bio, Inc INAB|Eterna Therapeutics, Inc. - Utang marang Ekuitas|GTBP - Utang marang Ekuitas|APTO: Utang marang Ekuitas|Utang marang Ekuitas MEIP|VINC (Vincerx Pharma) - Utang marang Modal